ETFMG Treatments, Testing and Advancements ETF – AMEX:GERM
Market closed
Open in 2 days
ETFMG Treatments, Testing and Advancements ETF stock price monthly change
-0.10%
month
ETFMG Treatments, Testing and Advancements ETF stock price quarterly change
+6.41%
quarter
ETFMG Treatments, Testing and Advancements ETF stock price yearly change
-10.27%
year
ETFMG Treatments, Testing and Advancements ETF key metrics
Market Cap | 9.58M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeETFMG Treatments, Testing and Advancements ETF stock price history
ETFMG Treatments, Testing and Advancements ETF stock forecast
ETFMG Treatments, Testing and Advancements ETF financial statements
ETFMG Treatments, Testing and Advancements ETF other data
Horiba: Wonderful Japanese Company At A Very Attractive Price
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Quest Diagnostics: Valuation Looks Good As Covid Testing Demand Tapers
Dynavax: Evolving Endemic Situation Adds To Its Risk
Airline-Health Care Rotation
-
When is ETFMG Treatments, Testing and Advancements ETF's next earnings date?
Unfortunately, ETFMG Treatments, Testing and Advancements ETF's (GERM) next earnings date is currently unknown.
-
Does ETFMG Treatments, Testing and Advancements ETF pay dividends?
Yes, ETFMG Treatments, Testing and Advancements ETF pays dividends and its trailing 12-month yield is 1.09% with 0% payout ratio. The last ETFMG Treatments, Testing and Advancements ETF stock dividend of $0.04 was paid on 23 Sep 2021.
-
How much money does ETFMG Treatments, Testing and Advancements ETF make?
ETFMG Treatments, Testing and Advancements ETF has a market capitalization of 9.58M.
-
What is ETFMG Treatments, Testing and Advancements ETF's stock symbol?
ETFMG Treatments, Testing and Advancements ETF is traded on the AMEX under the ticker symbol "GERM".
-
What is ETFMG Treatments, Testing and Advancements ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of ETFMG Treatments, Testing and Advancements ETF?
Shares of ETFMG Treatments, Testing and Advancements ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When ETFMG Treatments, Testing and Advancements ETF went public?
ETFMG Treatments, Testing and Advancements ETF is publicly traded company for more then 5 years since IPO on 18 Jun 2020.
ETFMG Treatments, Testing and Advancements ETF company profile:
Exchange:
AMEX
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
,
CIK: 0001467831
ISIN: US0321085815
:
